(ACO) regulations - American Society of Anesthesiologists

More documents

Recommendations

Info

CMS-1345-P 190 Domain Measure Title & Description CMS Program, NQF Measure Number, Measure Steward 52. At Risk Population – Coronary Artery Disease 53. At Risk Population – Coronary Artery Disease Coronary Artery Disease (CAD) Composite: All or Nothing Scoring • Oral Antiplatelet Therapy Prescribed for Patients with CAD • Drug Therapy for Lowering LDL- Cholesterol • Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) • LDL Level
CMS-1345-P 191 Domain Measure Title & Description CMS Program, NQF Measure Number, Measure Steward 54. At Risk Population – Coronary Artery Disease 55. At Risk Population – Coronary Artery Disease 56. At Risk Population – Coronary Artery Disease Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL- Cholesterol Percentage <strong>of</strong> patients aged 18 years and older with a diagnosis <strong>of</strong> CAD who were prescribed a lipid-lowering therapy (based on current ACC/AHA guidelines). The LDL-C treatment goal is
Page 1 and 2:
DEPARTMENT OF HEALTH AND HUMAN SERV
Page 3 and 4:
CMS-1345-P 3 Centers for Medicare &
Page 5 and 6:
CMS-1345-P 5 C. Overview and Intent
Page 7 and 8:
CMS-1345-P 7 7. Aligning ACO Qualit
Page 9 and 10:
CMS-1345-P 9 CCNC Community Care of
Page 11 and 12:
CMS-1345-P 11 SSN TIN Social Securi
Page 13 and 14:
CMS-1345-P 13 better coordinate car
Page 15 and 16:
CMS-1345-P 15 and efficient service
Page 17 and 18:
CMS-1345-P 17 ACO shall have at lea
Page 19 and 20:
CMS-1345-P 19 program or demonstrat
Page 21 and 22:
CMS-1345-P 21 Section 1899(d)(3) of
Page 23 and 24:
CMS-1345-P 23 Section 1899 (i) of t
Page 25 and 26:
CMS-1345-P 25 • An ACO will manag
Page 27 and 28:
CMS-1345-P 27 providers participati
Page 29 and 30:
CMS-1345-P 29 The Affordable Care A
Page 31 and 32:
CMS-1345-P 31 establish an estimate
Page 33 and 34:
CMS-1345-P 33 personal physicians;
Page 35 and 36:
CMS-1345-P 35 • Experience with n
Page 37 and 38:
CMS-1345-P 37 when looking at the e
Page 39 and 40:
CMS-1345-P 39 Medicare FFS benefici
Page 41 and 42:
CMS-1345-P 41 by only those ACO par
Page 43 and 44:
CMS-1345-P 43 Since the statute req
Page 45 and 46:
CMS-1345-P 45 For FQHCs and RHCs, t
Page 47 and 48:
CMS-1345-P 47 individual practition
Page 49 and 50:
CMS-1345-P 49 additional Medicare e
Page 51 and 52:
CMS-1345-P 51 The ACO's legal entit
Page 53 and 54:
CMS-1345-P 53 We note that by propo
Page 55 and 56:
CMS-1345-P 55 and administrative sy
Page 57 and 58:
CMS-1345-P 57 governance would crea
Page 59 and 60:
CMS-1345-P 59 demonstration, partic
Page 61 and 62:
CMS-1345-P 61 We believe that these
Page 63 and 64:
CMS-1345-P 63 • Clinical manageme
Page 65 and 66:
CMS-1345-P 65 participants and ACO
Page 67 and 68:
CMS-1345-P 67 Section 1899(b)(2)(A)
Page 69 and 70:
CMS-1345-P 69 be subject to the req
Page 71 and 72:
CMS-1345-P 71 program while still f
Page 73 and 74:
CMS-1345-P 73 Thus, we considered w
Page 75 and 76:
CMS-1345-P 75 addressing situations
Page 77 and 78:
CMS-1345-P 77 include provisions fo
Page 79 and 80:
CMS-1345-P 79 b. Processes to Promo
Page 81 and 82:
CMS-1345-P 81 • Telehealth. • T
Page 83 and 84:
CMS-1345-P 83 centeredness that is
Page 85 and 86:
CMS-1345-P 85 mechanism for coordin
Page 87 and 88:
CMS-1345-P 87 We are soliciting com
Page 89 and 90:
CMS-1345-P 89 to ensure that survey
Page 91 and 92:
CMS-1345-P 91 panel. Such a proposa
Page 93 and 94:
CMS-1345-P 93 addressing disparitie
Page 95 and 96:
CMS-1345-P 95 Individualized plans
Page 97 and 98:
CMS-1345-P 97 beneficiaries by mini
Page 99 and 100:
CMS-1345-P 99 a. Compliance Plans W
Page 101 and 102:
CMS-1345-P 101 generated by ACO par
Page 103 and 104:
CMS-1345-P 103 C. Establishing the
Page 105 and 106:
CMS-1345-P 105 After evaluating the
Page 107 and 108:
CMS-1345-P 107 when the final payme
Page 109 and 110:
CMS-1345-P 109 performance of ACO p
Page 111 and 112:
CMS-1345-P 111 cost-effectiveness o
Page 113 and 114:
CMS-1345-P 113 they identify priori
Page 115 and 116:
CMS-1345-P 115 generally bars the d
Page 117 and 118:
CMS-1345-P 117 acting on behalf of
Page 119 and 120:
CMS-1345-P 119 previous year's hist
Page 121 and 122:
CMS-1345-P 121 providers/suppliers.
Page 123 and 124:
CMS-1345-P 123 permitted under the
Page 125 and 126:
CMS-1345-P 125 and the claim paymen
Page 127 and 128:
CMS-1345-P 127 measurement activiti
Page 129 and 130:
CMS-1345-P 129 beneficiary choice:
Page 131 and 132:
CMS-1345-P 131 promote trust and pe
Page 133 and 134:
CMS-1345-P 133 beneficiaries. We an
Page 135 and 136:
CMS-1345-P 135 ensure that ACOs und
Page 137 and 138:
CMS-1345-P 137 eligibility since th
Page 139 and 140: CMS-1345-P 139 or to providers or s
Page 141 and 142: CMS-1345-P 141 ACO and the eligibil
Page 143 and 144: CMS-1345-P 143 From a technical, op
Page 145 and 146: CMS-1345-P 145 beneficiaries would
Page 147 and 148: CMS-1345-P 147 associated with thos
Page 149 and 150: CMS-1345-P 149 pediatric medicine,"
Page 151 and 152: CMS-1345-P 151 care services" on th
Page 153 and 154: CMS-1345-P 153 better address the d
Page 155 and 156: CMS-1345-P 155 assignment from year
Page 157 and 158: CMS-1345-P 157 appropriate safeguar
Page 159 and 160: CMS-1345-P 159 ACO only when he or
Page 161 and 162: CMS-1345-P 161 We propose to implem
Page 163 and 164: CMS-1345-P 163 quality and shared s
Page 165 and 166: CMS-1345-P 165 chosen. We seek comm
Page 167 and 168: CMS-1345-P 167 measures to assess t
Page 169 and 170: CMS-1345-P 169 • To the extent pr
Page 171 and 172: CMS-1345-P 171 data collection and
Page 173 and 174: CMS-1345-P 173 improving ACO qualit
Page 175 and 176: CMS-1345-P 175 Domain Measure Title
Page 187 and 188: CMS-1345-P 187 43. At Risk Populati
Page 189: CMS-1345-P 189 50. At Risk Populati
Page 195 and 196: CMS-1345-P 195 Information on Physi
Page 197 and 198: CMS-1345-P 197 associated with clai
Page 199 and 200: CMS-1345-P 199 be required to popul
Page 201 and 202: CMS-1345-P 201 as that term is defi
Page 203 and 204: CMS-1345-P 203 Table 2: Five Measur
Page 205 and 206: CMS-1345-P 205 sided shared savings
Page 207 and 208: CMS-1345-P 207 Table 4: Total Point
Page 209 and 210: CMS-1345-P 209 Medicare program. Fu
Page 211 and 212: CMS-1345-P 211 for the first perfor
Page 213 and 214: CMS-1345-P 213 of quality acknowled
Page 215 and 216: CMS-1345-P 215 (Option 1) but using
Page 217 and 218: CMS-1345-P 217 ACO would qualify fo
Page 219 and 220: CMS-1345-P 219 future rulemaking. W
Page 221 and 222: CMS-1345-P 221 proposing greater al
Page 223 and 224: CMS-1345-P 223 6. Public Reporting
Page 225 and 226: CMS-1345-P 225 efficiency, effectiv
Page 227 and 228: CMS-1345-P 227 this information ava
Page 229 and 230: CMS-1345-P 229 Specifically, we see
Page 231 and 232: CMS-1345-P 231 We considered severa
Page 233 and 234: CMS-1345-P 233 Track 2: More experi
Page 235 and 236: CMS-1345-P 235 determinations about
Page 237 and 238: CMS-1345-P 237 beneficiaries during
Page 239 and 240: CMS-1345-P 239 truncate an assigned
Page 241 and 242:
CMS-1345-P 241 the demonstration wh
Page 243 and 244:
CMS-1345-P 243 We seek comments abo
Page 245 and 246:
CMS-1345-P 245 Of these two methods
Page 247 and 248:
CMS-1345-P 247 other factor could b
Page 249 and 250:
CMS-1345-P 249 Capitation Rates, Pa
Page 251 and 252:
CMS-1345-P 251 A model that uses be
Page 253 and 254:
CMS-1345-P 253 option to audit ACOs
Page 255 and 256:
CMS-1345-P 255 Thus, we are not pro
Page 257 and 258:
CMS-1345-P 257 subsequently receive
Page 259 and 260:
CMS-1345-P 259 This benchmark is su
Page 261 and 262:
CMS-1345-P 261 nationwide under the
Page 263 and 264:
CMS-1345-P 263 benchmark based on t
Page 265 and 266:
CMS-1345-P 265 upon the number of M
Page 267 and 268:
CMS-1345-P 267 beneficiaries. In re
Page 269 and 270:
CMS-1345-P 269 and share in savings
Page 271 and 272:
CMS-1345-P 271 a result of normal y
Page 273 and 274:
CMS-1345-P 273 • 50 percent or mo
Page 275 and 276:
CMS-1345-P 275 • Among older adul
Page 277 and 278:
CMS-1345-P 277 of dual eligible ben
Page 279 and 280:
CMS-1345-P 279 they incur shareable
Page 281 and 282:
CMS-1345-P 281 for the Medicare pro
Page 283 and 284:
CMS-1345-P 283 and efficiency of ca
Page 285 and 286:
CMS-1345-P 285 have also suggested
Page 287 and 288:
CMS-1345-P 287 providers' willingne
Page 289 and 290:
CMS-1345-P 289 expect to consider i
Page 291 and 292:
CMS-1345-P 291 two years under the
Page 293 and 294:
CMS-1345-P 293 Design Element Minim
Page 295 and 296:
CMS-1345-P 295 performance) under t
Page 297 and 298:
CMS-1345-P 297 For purposes of the
Page 299 and 300:
CMS-1345-P 299 proposed that for th
Page 301 and 302:
CMS-1345-P 301 For example, a two-s
Page 303 and 304:
CMS-1345-P 303 depends on the ACO's
Page 305 and 306:
CMS-1345-P 305 have solicited comme
Page 307 and 308:
CMS-1345-P 307 the ACO's repayment
Page 309 and 310:
CMS-1345-P 309 the growth in Medica
Page 311 and 312:
CMS-1345-P 311 relied upon by us in
Page 313 and 314:
CMS-1345-P 313 requirements not set
Page 315 and 316:
CMS-1345-P 315 entity is in an arra
Page 317 and 318:
CMS-1345-P 317 disease) or benefici
Page 319 and 320:
CMS-1345-P 319 information. If the
Page 321 and 322:
CMS-1345-P 321 ● Failure to compl
Page 323 and 324:
CMS-1345-P 323 harm to beneficiarie
Page 325 and 326:
CMS-1345-P 325 determinations would
Page 327 and 328:
CMS-1345-P 327 Shared Savings Progr
Page 329 and 330:
CMS-1345-P 329 CMS and OIG have joi
Page 331 and 332:
CMS-1345-P 331 The Antitrust Policy
Page 333 and 334:
CMS-1345-P 333 previously. Such an
Page 335 and 336:
CMS-1345-P 335 protects beneficiary
Page 337 and 338:
CMS-1345-P 337 both Medicare benefi
Page 339 and 340:
CMS-1345-P 339 J. Overlap with Othe
Page 341 and 342:
CMS-1345-P 341 CMS shared savings p
Page 343 and 344:
CMS-1345-P 343 Shared Savings Progr
Page 345 and 346:
CMS-1345-P 345 improve the Shared S
Page 347 and 348:
CMS-1345-P 347 V. Regulatory Impact
Page 349 and 350:
CMS-1345-P 349 The Shared Savings P
Page 351 and 352:
CMS-1345-P 351 ACOs work to improve
Page 353 and 354:
CMS-1345-P 353 presumably provide a
Page 355 and 356:
CMS-1345-P 355 • Number of partic
Page 357 and 358:
CMS-1345-P 357 distribution. With t
Page 359 and 360:
CMS-1345-P 359 c. Further Considera
Page 361 and 362:
CMS-1345-P 361 More specifically, w
Page 363 and 364:
CMS-1345-P 363 program and uncertai
Page 365 and 366:
CMS-1345-P 365 Savings Program at 7
Page 367 and 368:
CMS-1345-P 367 ACO-attributed claim
Page 369 and 370:
CMS-1345-P 369 Category Costs COSTS
Page 371 and 372:
CMS-1345-P 371 For the reasons set
Page 373 and 374:
CMS-1345-P 373 (2) Program requirem
Page 375 and 376:
CMS-1345-P 375 Act. Hospital means
Page 377 and 378:
CMS-1345-P 377 meet the minimum qua
Page 379 and 380:
CMS-1345-P 379 (C) Begin to operate
Page 381 and 382:
CMS-1345-P 381 (D) The civil moneta
Page 383 and 384:
CMS-1345-P 383 prior to the start o
Page 385 and 386:
CMS-1345-P 385 for populations, and
Page 387 and 388:
CMS-1345-P 387 monitoring and evalu
Page 389 and 390:
CMS-1345-P 389 (i) It plans to use
Page 391 and 392:
CMS-1345-P 391 (1) Have a beneficia
Page 393 and 394:
CMS-1345-P 393 who were an ACO part
Page 395 and 396:
CMS-1345-P 395 amount for the patie
Page 397 and 398:
CMS-1345-P 397 under §425.7(b). An
Page 399 and 400:
CMS-1345-P 399 (ii) To be responsib
Page 401 and 402:
CMS-1345-P 401 §425.8 ACO quality
Page 403 and 404:
CMS-1345-P 403 (2) CMS scores indiv
Page 405 and 406:
CMS-1345-P 405 (a) Monitoring of AC
Page 407 and 408:
CMS-1345-P 407 required measure dat
Page 409 and 410:
CMS-1345-P 409 (5) The procedures e
Page 411 and 412:
CMS-1345-P 411 demonstrate in its a
Page 413 and 414:
CMS-1345-P 413 days of the notice o
Page 415 and 416:
CMS-1345-P 415 original notice of d
Page 417 and 418:
CMS-1345-P 417 (c) Notwithstanding
Page 419 and 420:
CMS-1345-P 419 (ii) Quality perform
Page 421 and 422:
CMS-1345-P 421 (i) The beneficiary
Page 423 and 424:
CMS-1345-P 423 terminated from the
Page 425 and 426:
CMS-1345-P 425 inclusion of additio
Page 427 and 428:
CMS-1345-P 427 individuals, better
Page 429:
CMS-1345-P 04/07/2011] [FR Doc. 201
show all

(ACO) regulations - American Society of Anesthesiologists

Create successful ePaper yourself

Delete template?

Save as template?